Clinical trials
Terminated Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 1 |
| 2009 | 3 |
| 2010 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2020 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kiadis Pharma | 2 |
| National Cancer Institute (NCI) | 2 |
| University Health Network, Toronto | 2 |
| Amgen | 1 |
| Children's Hospital of Philadelphia | 1 |
| Dana-Farber Cancer Institute | 1 |
| Gilead Sciences | 1 |
| Hoffmann-La Roche | 1 |
| Martin, Paul | 1 |
| MedImmune LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 15 |
| Recurrence | 5 |
| Leukemia, Myeloid, Acute | 4 |
| Burkitt Lymphoma | 3 |
| Graft vs Host Disease | 3 |
| Hematologic Neoplasms | 3 |
| Leukemia | 3 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Multiple Myeloma | 3 |
| Myelodysplastic Syndromes | 3 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.